Independent journalism for India—rooted in the mountains
Wednesday, March 4, 2026

Top 5 This Week

EDITOR'S PICK

Vaccine makers could make Omicron-specific booster, says Fauci

WASHINGTON, December 3

COVID-19 vaccine makers have contingency plans to deal with the Omicron variant that include a combination vaccine against the original version and the variant as well as a variant-specific booster dose, a top U.S. health official said on Friday.

The US government is working with Moderna, Pfizer, and J&J on multiple contingency plans, infectious disease expert Anthony Fauci told reporters at a White House briefing.

“One is to rev up the production of the vaccines that they already have. The next is to make, for example, a bivalent, where you have the vaccine against both the ancestral strain and the new variant, and the other is to make a variant-specific boost,” said Fauci.

“They are now assuming they may have to do that and are being prepared for that,” he added.

Data from a National Institutes of Health study strongly suggest that existing boosters provide cross protection against a number of variants, including Omicron, Fauci said.

“Although we haven’t proven it yet, there’s every reason to believe that if you get vaccinated and boosted that you would have at least some degree of cross-protection, very likely against severe disease, even against the Omicron variant.” The U.S. Centers for Disease Control and Prevention is working with local authorities to investigate suspect cases of the Omicron variant in states other than those where cases have already been reported, Director Rochelle Walensky said at the briefing.

There have been cases of Omicron detected in about 40 countries, she said, but the Delta variant remains the dominant strain in the United States.

“I know that the news is focused on Omicron. But we should remember that 99.9% of cases in the country right now are from the Delta variant. Delta continues to drive cases across the country, especially in those who are unvaccinated,” she said. – Reuters



(The article is generated from feeds via CT, The Chenab Times staff didn’t write this news.)

❤️ Support Independent Journalism

Your contribution keeps our reporting free, fearless, and accessible to everyone.

Supporter

99/month

Choose ₹99 × 12 months
MOST POPULAR

Patron

199/month

Choose ₹199 × 12 months

Champion

499/month

Choose ₹499 × 12 months
TOP TIER

Guardian

999/month

Choose ₹999 × 12 months

Or make a one-time donation

Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle









(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
logo

The Chenab Times News Desk

News Desk CT
News Desk CThttp://thechenabtimes.com
The Chenab Times News Desk

Popular Articles